Two-Thirds of Cannabis Users Report Better Sleep, AASM Survey Finds

Survey Methodology and Sample Size

The American Academy of Sleep Medicine surveyed 2,003 American adults in May 2026, asking about cannabis use patterns and perceived sleep impacts. The poll didn't distinguish between medical and adult-use consumers. It also skipped questions about product types or dosing regimens. AASM released the findings on June 2, 2026, without peer review or publication in a medical journal.

Two-Thirds Report Sleep Quality Improvement

Among the 33 percent of respondents who use cannabis, 67 percent said marijuana makes their sleep quality "significantly" or "slightly" better. That translates to roughly 22 percent of all survey respondents reporting cannabis-aided sleep improvement. The academy didn't release crosstabs showing frequency of use, product format, or THC versus CBD preference.

No Data on Product Type or Cannabinoid Profile

Respondents weren't asked whether they use flower, edibles, tinctures, or vaporizers. The survey also didn't distinguish between THC-dominant, CBD-dominant, or balanced formulations. Sleep researchers have published conflicting data on whether THC disrupts REM sleep architecture over time, but this poll captured only subjective user perception—not polysomnography or actigraphy metrics.

Sleep Category Drives Product Development

Sleep formulations now account for an estimated 18 to 25 percent of ingestible SKU launches in regulated markets, according to product-tracking data from several state agencies. Brands including Wyld, Kiva, and Wana have released CBN-forward gummies marketed for sleep. The FDA hasn't evaluated those claims. Still, the AASM survey adds consumer-sentiment data to a category already seeing heavy R&D investment, and product developers are watching closely as the segment matures and consumers report back on efficacy over repeated use cycles.

AASM Position on Cannabis Remains Cautious

The American Academy of Sleep Medicine hasn't endorsed cannabis as a sleep aid. In prior statements, the organization has called for more randomized controlled trials before clinicians recommend THC or CBD for insomnia. The academy's decision to field this survey signals growing interest in patient behavior, even as its clinical guidance remains conservative.

What Sleep-Tech Platforms Are Tracking

Wearable sleep trackers from Oura, Whoop, and Fitbit have begun adding cannabis-use fields to their nightly surveys. Users can now correlate consumption with sleep stages. For background on how cannabis affects sleep architecture and why product developers are targeting this use case, see the CannIntel topic hub on Cannabis Sleep Research. The next data point to watch is whether longitudinal studies show tolerance effects that diminish perceived sleep benefits over months of nightly use.